TRIL

Trillium Therapeutics Inc.
TRIL

Overview Fund Activity
Delisted

TRIL was delisted on the 16th of November, 2021.

Back to rankings

26 hedge funds and large institutions have $40.3M invested in Trillium Therapeutics Inc. in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.

Holders
26
Holders Change
-3
Holders Change %
-10.34%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
6
Closed
5
Calls
$3K
Puts
$12K
Net Calls
-$9K
Net Calls Change
+$5K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$2.07M
2
WAAG
2
Wealth Alliance Advisory Group
Kansas
$126K
3
BFM
3
Boothbay Fund Management
New York
$117K
4
SLG
4
Stanley-Laman Group
Pennsylvania
$809K
5
UBS Group
5
UBS Group
Switzerland
$15K

Top Sellers

1
CAM
1
Cormorant Asset Management
Massachusetts
$2.9M
2
Deutsche Bank
2
Deutsche Bank
Germany
$493K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$673K
4
Millennium Management
4
Millennium Management
New York
$0
5
BBA
5
Baker Bros. Advisors
New York
$2.93M
Name Holding Trade Value Shares
Change 		Shares
Change %
Millennium Management
26
Millennium Management
New York
– -$82K -13,704 Closed
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
– -$31K -5,125 Closed
1832 Asset Management
28
1832 Asset Management
Ontario, Canada
– -$14K -2,500 Closed
Simplex Trading
29
Simplex Trading
Illinois
– -$5K -855 Closed
Bank of America
30
Bank of America
North Carolina
– -$5K -763 Closed
1
2